Status:

RECRUITING

Host Response to Infection and Treatment in Filarial Diseases

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

Filariasis

Helminthiasis

Eligibility:

All Genders

3-100 years

Brief Summary

This study will evaluate and treat patients with filarial infections to explore in depth the immunology of the disease, including susceptibility to infection, disease development, and response to trea...

Detailed Description

Patients admitted on this protocol will have, or be suspected of having, one of the filarial infections affecting humans. After routine clinical evaluation they will be studied in depth immunologicall...

Eligibility Criteria

  • INCLUSION CRITERIA:

Age 3-100 years.

Access to a primary medical care provider outside of the NIH.

Ability to give informed consent.

Clinical evidence suggestive of a filarial infection

EXCLUSION CRITERIA:

Although pregnant or nursing women can be enrolled, they will be excluded from receiving treatment while pregnant or breastfeeding

Less than 3 year of age; greater than 100 years of age

Any condition that the investigator feels put the subject at unacceptable risk for participation in the study

Key Trial Info

Start Date :

March 15 1991

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT00001230

Start Date

March 15 1991

Last Update

May 1 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892